For help on how to get the results you want, see our search tips.
1589 results
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Pregabalin Zentiva (updated)
pregabalin, Anxiety Disorders; Epilepsy
Date of authorisation: 17/07/2015,
, Revision: 11, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Janssen (updated)
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021,
, 
, Revision: 15, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): Ozawade (updated)
pitolisant, Sleep Apnea, Obstructive
Date of authorisation: 01/09/2021, Revision: 1, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Retsevmo (updated)
Selpercatinib, Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms
Date of authorisation: 11/02/2021,, , Revision: 2, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): Twinrix Paediatric (updated)
hepatitis A virus (inactivated), hepatitis B surface antigen, Immunization; Hepatitis B; Hepatitis A
Date of authorisation: 10/02/1997, Revision: 22, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Twinrix Adult (updated)
hepatitisĀ A virus (inactivated), hepatitis B surface antigen, Hepatitis B; Hepatitis A; Immunization
Date of authorisation: 19/09/1996, Revision: 22, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Fendrix (updated)
hepatitis B surface antigen, Hepatitis B; Immunization
Date of authorisation: 02/02/2005, Revision: 11, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Herzuma (updated)
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 09/02/2018,, 
, Revision: 14, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): Tecfidera (updated)
dimethyl fumarate, Multiple Sclerosis
Date of authorisation: 30/01/2014, Revision: 22, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Ambirix (updated)
hepatitis A virus (inactivated), hepatitis B surface antigen, Hepatitis B; Hepatitis A; Immunization
Date of authorisation: 30/08/2002, Revision: 16, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Ikervis (updated)
ciclosporin, Corneal Diseases
Date of authorisation: 19/03/2015, Revision: 8, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Pradaxa (updated)
Dabigatran etexilate mesilate, Arthroplasty, Replacement; Venous Thromboembolism
Date of authorisation: 17/03/2008,
, Revision: 36, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): Alimta (updated)
pemetrexed, Mesothelioma; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2004, Revision: 26, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Azilect (updated)
rasagiline, Parkinson Disease
Date of authorisation: 21/02/2005, Revision: 22, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Symtuza (updated)
darunavir, cobicistat, emtricitabine, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/09/2017,, Revision: 12, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): Rezolsta (updated)
darunavir, cobicistat, HIV Infections
Date of authorisation: 19/11/2014, Revision: 13, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Prezista (updated)
darunavir, HIV Infections
Date of authorisation: 11/02/2007, Revision: 52, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Optruma (updated)
raloxifene hydrochloride, Osteoporosis, Postmenopausal
Date of authorisation: 05/08/1998, Revision: 25, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Skyrizi (updated)
Risankizumab, Psoriasis; Arthritis, Psoriatic
Date of authorisation: 26/04/2019,, Revision: 8, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): Movymia (updated)
teriparatide, Osteoporosis
Date of authorisation: 11/01/2017,, Revision: 10, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): Rekambys (updated)
rilpivirine, HIV Infections
Date of authorisation: 17/12/2020,, Revision: 4, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): Semglee (updated)
insulin glargine, Diabetes Mellitus
Date of authorisation: 23/03/2018,, , Revision: 6, Authorised, Last updated: 14/01/2022
-
List item
Human medicine European public assessment report (EPAR): Xromi (updated)
hydroxycarbamide, Anemia, Sickle Cell
Date of authorisation: 01/07/2019, Revision: 3, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Rotarix (updated)
human rotavirus, live attenuated, Immunization; Rotavirus Infections
Date of authorisation: 21/02/2006, Revision: 39, Authorised, Last updated: 14/01/2022 -
List item
Human medicine European public assessment report (EPAR): Effentora (updated)
fentanyl, Pain; Cancer
Date of authorisation: 04/04/2008, Revision: 25, Authorised, Last updated: 14/01/2022